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Single Bout of Social Defeat
Repeated Social Defeat
Figure 1.
C57BL/6J mice were separated into 3 testing groups and allowed to acclimate to their new 
environment. Also, A CD-1 Mouse is Introduced as a “Bully” to the C57Bl/6J Mice.
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• 48 Male C57BL/6J Mice (6 Weeks Old) (Jackson Lab) were separated into 3 testing groups (Control,
Novel, and Aggressor) and allowed to acclimate to the new environment.
• Novel C-57 Mice: Any Mouse that is from the same species (C57BL/6J) of the testing mouse but, from a
different testing environment.
• Aggressor Mice: A Different strain of Mice (CD-1) were used to Model as a “Bully” (Retired Breeding
Male) and shifted into the testing environment with C57BL/J6 Mice.
• Different Types of Treatment
• Control: A group of mice were sacrificed after 2 hour bout within the same community.
• Single Bout: A group of mice were sacrificed after a 2 hour bout of social defeat and interactions with
a relative mouse (same species).
• Repeated Social Defeat: A group of mice were sacrificed after 12 hours after the final bout of 2 hour
bouts of social defeat for 6 days and interactions with a foreign aggressive mouse (different species).
• Liver Tissue Samples were collected, Homogenized, and then stored at -80 oC
• Western Blots
• Using the BCA Assay (Thermo Scientific Pierce Reagent A (Ref#23228), Pierce Reagent B
(Ref#23224)) Total Protein Concentration was determined and Samples were prepared (50μg/25 μL).
• After 7.5% Acrylamide Gels (Bio-Rad) were molded, Proteins were loaded into wells and separated by
electrophoresis, transferred to membrane, and blocked with 5% BSA.
• Antibodies need to be prepared and labeled to be applied onto the Membrane (PDVF).
• Phospho-Related p65 (Cell Signaling) (Ref#3033)
• Total-p65 (Cell Signaling) (Ref#4764)
• ß-Tubulin - Loading Control (Cell Signaling) (Ref#2146)
• Membranes need to be coated with ECF Substrate (GE Healthcare Amersham ECF Substrate)
(Vendor#RPN-5785) and then imaged.(Typhoon Scanner).
• IQTools: Used to convert .gel files to .tif files.
• Adobe Photoshop and ImageJ (NIH Resource: Free): Used to obtain the integrated density values for the
bands of interest.
• GraphPad Prism (Version 8): Used to obtain visual aid and identifying significant values by completing
various tests (ANOVA, Tukey, Kruskal-Wallis, and Unpaired-T-Test).
Future Directions
1. Investigate expressions levels with other Relative Inflammatory
Mediators.
2. Investigate expression values of NF-kB-p65 immediately after the
final bout of Repeated Social Defeat.
3. Investigate Inflammatory Mediators in the Central Nervous System
(CNS) and the Peripheral Nervous System (PNS)
4. Investigate The Action Of ß-Funaltrexamine (ß-FNA), A μ-Opioid
Antagonist That Previous Studies Have Shown Inhibits Neuro-
Inflammation
5. Repeat Previous Experiment with Female Mice (NF-kB-p65) under
same conditions.
Abstract
Introduction
Background: About 30 million people in the United States suffer from mood and anxiety disorders, thus
creating personal and economical strain. Developing new medications and treatment strategies is
imperative for those who suffer with these disorders and those who do not respond to available
treatments.3-5 A key component that plays an important role in brain and liver disorders is
neuroinflammation. Unfortunately, there are only a few drugs on the market currently that target
neuroinflammation. For Example, β-funaltrexamine (β-FNA), a variant of naltrexone, inhibits the
activation of astrocytes. 3-7 This has shown to reduce the jauntiness behavior caused by exposure to a
bacterial product7-8. The interest of this study is to seek the therapeutic relevance of β-FNA as a
neuroprotective agent in cases of extreme social stress or bullying.5 An efficient model for implementing
extreme social stress is the Repeated Social Defeat (RSD). This involves in a community of mice
(C57BL/6J) being disturbed by adding an aggressor or “bully” mouse that is larger and darker than the
community of mice.7 Also, another group of mice received only a single bout of social defeat. They were
used as a control to refer if a different strain of mouse causes a higher level of stress than an addition of the
same strain.
Purpose: The overall purpose of this experiment is to identify the effects of RSD on neuroinflammation,
and develop an experiment for β-FNA in relation to neuroinflammation.
Analysis: Western Blot Analysis1 was executed to identify NF-kB p65 levels in the liver of mice that
underwent social defeat8. Mice, Both Novel C-57 and Aggressor, which were exposed to a single bout of
social defeat, had higher levels of p65 when comparing to the control mice p65 levels. Also, the RSD Mice
expressed similar results as the Single Bout of Social Defeat Mice.
Conclusion: This highlights that the community of mice had extreme stress when any mice was added to
their community regardless of strain, color, or aggressiveness. We hypothesize that these results and
experiments will be helpful and informational to attain neuroinflammation drugs for therapeutic purposes.
An increase in mood and anxiety disorders causes a demand to invent new medications and treatment
strategies to reduce neuro-inflammation in the brain and liver. The drug of interest, β-funaltrexamine
(β-FNA) has shown to reduce jauntiness behavior in mice from a previous experiment. We currently
are determining if Social Stress increases when a different strain or same strain of mouse is introduced
into the community of mice. This project, Repeated Social Defeat (RSD) has 2 test groups, Single Bout
of Social Defeat and RSD to analyze different stress levels through NF-kB p65 Activation levels. This
activation level was determined by using Western Blot Analysis. The Results of this experiment showed
that the community of mice had increased stress levels regardless of the strain of mice. This experiment
will be footstep for the upcoming implementation of β-FNA) as a therapeutic drug.
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Results
Figure 2A.
The Effect of NF-kB p-65 Activation (Single Bout of Social Defeat)
Determined By Using Western Blots.
Figure 2B. 
The Effect of NF-kB p-65 Expression in Single Bout of Social Defeat.
Determined By Using Western Blots.
Figure 3A. 
The Effect of NF-kB p-65 Activation in Repeated Social Defeat.
Determined By Using Western Blots.
Figure 3B.
The Effect of NF-kB p-65 Expression in Repeated Social Defeat.
Determined By Using Western Blots.
Test Group 1
Single Bout
Sacrificed after 2 
hours of bout.
Test Group 2
Repeated Social 
Defeat
Sacrificed after 12 
hours after final 2 
hours of bout for 6
consecutive days.
As expressed in figure 2A, the addition of the novel C-57 and the
aggressor in the single bout of social defeat had an increase in NF-
kB p65 activation, thus an increase in inflammatory signaling. On the
other hand, the activation levels in the repeated social defeat aggressor
did not increase as significant as the single bout for social defeat.
• These results indicate that when an unfamiliar mouse is introduced
into an established community, the induced stress leads to an
increase in inflammatory signaling.
• This also shows that the amount of time the mice are interacting
with the other mouse has no effect on the stress level of the
residing mice community.
• A drug with anti-inflammatory capabilities such as the μ-opioid
antagonist ß-FNA, could be characterized as a therapeutic
treatment for mood and anxiety disorders.
